Evidence map›Paper›PMID 15630594›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2005

The telomerase cycle: normal and pathological aspects.

Michele Brunori, Pierre Luciano, Eric Gilson, Vincent Géli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Telomeres and telomerase in the clinical management of colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  9. Article
  10. Article
  11. Telomere maintenance, function and evolution: the yeast paradigm.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2005
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michele BrunoriLaboratoire de Biologie Moleculaire de la Cellule, l'Ecole Normale de Lyon, CNRS UMR5161, INRA U1237, IFR12846 Allée d'Italie, 69364 Lyon cedex 07, France.
Pierre Luciano
Eric Gilson
Vincent Géli
Centre National de la Recherche Scientifique · FRLaboratoire de Biologie et Modélisation de la Cellule · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomeres are nucleoprotein complexes that cap the end of eukaryotic chromosomes and are essential for their function and stability. Telomerase, a reverse transcriptase that extends the single-stranded G-rich 3' protruding ends of chromosomes, stabilizes telomere length in germ line cells and regenerative tissues as well as in tumor cells. In the absence of telomerase telomeres shorten with cell division, a process able to trigger cell growth arrest. When telomerase is present in the cell, its activity is tightly regulated at its site of action by factors specifically bound to the telomeric DNA. Recent data indicate that telomeres reorganize during the cell cycle. This review summarizes our current knowledge on how telomeres are dynamically organized and remodeled during cell cycle and stress response, pointing out the conservation and the difference between yeast and human. We then focus on the cellular consequences of telomere modifications in normal and cancer cells. This leads to a discussion of the different roles, seemingly contradictory, of telomeres and telomerase during the initiation and the progression of a cancer.

Indexed as

AnimalsCell CycleGenes, Tumor SuppressorHumansOncogenesReference ValuesTelomeraseTelomereYeastsTelomerase

Identifiers

PMID15630594
OpenAlexW2115577008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.